M Salmon

6.9k total citations · 1 hit paper
127 papers, 5.6k citations indexed

About

M Salmon is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, M Salmon has authored 127 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 41 papers in Molecular Biology and 34 papers in Physiology. Recurrent topics in M Salmon's work include Asthma and respiratory diseases (27 papers), Receptor Mechanisms and Signaling (17 papers) and T-cell and B-cell Immunology (17 papers). M Salmon is often cited by papers focused on Asthma and respiratory diseases (27 papers), Receptor Mechanisms and Signaling (17 papers) and T-cell and B-cell Immunology (17 papers). M Salmon collaborates with scholars based in United Kingdom, United States and Canada. M Salmon's co-authors include Christopher D. Buckley, Kian Fan Chung, Janet M. Lord, Arne N. Akbar, Peter J. Barnes, Andrew Filer, Dagmar Scheel‐Toellner, George Janossy, David Adams and Philip L. Shields and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

M Salmon

124 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro

2015 585 citations Kambez H. Benam, Rémi Villenave et al. Nature Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Salmon United Kingdom	42	2.0k	1.4k	1.1k	1.0k	778	127	5.6k
Y. Emil United States	31	2.1k 1.1×	1.3k 0.9×	1.1k 1.1×	1.5k 1.4×	356 0.5×	49	5.1k
Sara M. Rankin United Kingdom	41	3.1k 1.6×	1.7k 1.2×	1.2k 1.1×	589 0.6×	981 1.3×	84	7.1k
Donald L. Kreutzer United States	48	1.8k 0.9×	2.7k 1.9×	539 0.5×	954 0.9×	1.2k 1.5×	165	8.0k
Peter J. Lenting France	57	2.2k 1.1×	1.8k 1.3×	996 0.9×	567 0.6×	518 0.7×	208	10.0k
Linda M. McManus United States	44	1.1k 0.6×	2.4k 1.7×	887 0.8×	426 0.4×	565 0.7×	99	6.4k
Maureen R. Horton United States	42	3.1k 1.6×	2.3k 1.7×	748 0.7×	1.4k 1.4×	960 1.2×	91	7.3k
Andrew C. Issekutz Canada	54	3.1k 1.5×	2.0k 1.5×	802 0.8×	757 0.7×	718 0.9×	184	7.7k
Kenneth A. Ault United States	47	2.5k 1.3×	1.1k 0.8×	688 0.7×	682 0.7×	603 0.8×	102	7.3k
Peter Petzelbauer Austria	45	1.8k 0.9×	2.0k 1.5×	457 0.4×	490 0.5×	1.4k 1.8×	146	6.1k
Caroline Bonnans France	22	743 0.4×	1.5k 1.1×	561 0.5×	757 0.7×	836 1.1×	32	4.8k

Countries citing papers authored by M Salmon

Since Specialization

Citations

This map shows the geographic impact of M Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Salmon more than expected).

Fields of papers citing papers by M Salmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Salmon. The network helps show where M Salmon may publish in the future.

Co-authorship network of co-authors of M Salmon

This figure shows the co-authorship network connecting the top 25 collaborators of M Salmon. A scholar is included among the top collaborators of M Salmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Salmon. M Salmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nawroth, Janna, Carolina Lucchesi, Antonio Varone, et al.. (2020). A Microengineered Airway Lung Chip Models Key Features of Viral-induced Exacerbation of Asthma. American Journal of Respiratory Cell and Molecular Biology. 63(5). 591–600. 87 indexed citations

Yu, Hongshi, et al.. (2019). Estimation of Fraction Dissolved After Intratracheal Delivery of a Potent Janus Kinase Inhibitor, iJAK-001, with Low Solubility in Rat and Sheep: Impact of Preclinical PKPD on Inhaled Human Dose Projection. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(5). 251–265. 4 indexed citations

Cabal, Antonio, Khamir Mehta, David Ross, et al.. (2016). Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(4). 362–377. 17 indexed citations

Benam, Kambez H., Rémi Villenave, Carolina Lucchesi, et al.. (2015). Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nature Methods. 13(2). 151–157. 585 indexed citations breakdown →

Eckman, Joseph, Hyun‐Hee Lee, M Salmon, et al.. (2014). Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation. European Journal of Pharmacology. 743. 106–116. 10 indexed citations

Salmon, M, Mark A. Luttmann, James J. Foley, et al.. (2013). Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases. Journal of Pharmacology and Experimental Therapeutics. 345(2). 260–270. 64 indexed citations

Francis, Nigel, See Heng Wong, Peter Hampson, et al.. (2011). Lactoferrin inhibits neutrophil apoptosis via blockade of proximal apoptotic signaling events. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(10). 1822–1826. 26 indexed citations

Lainé, Dramane I., Mark A. Luttmann, James J. Foley, et al.. (2011). The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing. European Respiratory Journal. 38(Suppl 55). 3450–3450. 15 indexed citations

Yeo, Lorraine, Caroline Schmutz, Kai‐Michael Toellner, et al.. (2011). Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Annals of the Rheumatic Diseases. 70. A60–A60. 9 indexed citations

10.

Sauce, Delphine, Martin Larsen, John Curnow, et al.. (2006). EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood. 108(1). 11–18. 53 indexed citations

11.

Heydtmann, Mathis, Debbie L. Hardie, Philip L. Shields, et al.. (2006). Detailed Analysis of Intrahepatic CD8 T Cells in the Normal and Hepatitis C-Infected Liver Reveals Differences in Specific Populations of Memory Cells with Distinct Homing Phenotypes. The Journal of Immunology. 177(1). 729–738. 41 indexed citations

12.

Renzoni, Elisabetta, David A. Walsh, M Salmon, et al.. (2003). Interstitial Vascularity in Fibrosing Alveolitis. American Journal of Respiratory and Critical Care Medicine. 167(3). 438–443. 148 indexed citations

13.

Eynott, Paul R., David A. Groneberg, Alistair Noble, et al.. (2003). Role of Nitric Oxide in Chronic Allergen-Induced Airway Cell Proliferation and Inflammation. Journal of Pharmacology and Experimental Therapeutics. 304(1). 22–29. 46 indexed citations

14.

Hislop, Andrew D., Nancy Gudgeon, Margaret Callan, et al.. (2001). EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function. The Journal of Immunology. 167(4). 2019–2029. 183 indexed citations

15.

Huang, Tung‐Jung, El‐Bdaoui Haddad, M Salmon, et al.. (1999). Contribution of Bradykinin B1 and B2 Receptors in Allergen-induced Bronchial Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine. 160(5). 1717–1723. 42 indexed citations

16.

Hisada, Takeshi, M Salmon, Yasuyuki Nasuhara, & Kian Fan Chung. (1999). Cysteinyl-leukotrienes Partly Mediate Eotaxin-induced Bronchial Hyperresponsiveness and Eosinophilia in IL-5 Transgenic Mice. American Journal of Respiratory and Critical Care Medicine. 160(2). 571–575. 21 indexed citations

17.

Salmon, M, Hiroshi Koto, Oonagh T. Lynch, et al.. (1998). Proliferation of Airway Epithelium After Ozone Exposure: Effect of Apocynin and Dexamethasone. American Journal of Respiratory and Critical Care Medicine. 157(3). 970–977. 45 indexed citations

18.

Koto, Hiroshi, et al.. (1997). Role of Cytokine-induced Neutrophil Chemoattractant (CINC) in Ozone-induced Airway Inflammation and Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine. 156(1). 234–239. 51 indexed citations

19.

Gough, Andrew, Jeff Faint, P Wordsworth, M Salmon, & P. Emery. (1992). THE HLA CLASS II ASSOCIATIONS OF RHEUMATOID-ARTHRITIS CONFER SEVERITY NOT SUSCEPTIBILITY. Oxford University Research Archive (ORA) (University of Oxford). 35. 2 indexed citations

20.

Bacon, P A & M Salmon. (1987). Modes of Action of Second-line Agents. Scandinavian Journal of Rheumatology. 16(sup64). 17–24. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact